[go: up one dir, main page]

AU2298301A - Flavones as inducible nitric oxide synthase inhibitors, cyclooxygenase-2 inhibitors and potassium channel activators - Google Patents

Flavones as inducible nitric oxide synthase inhibitors, cyclooxygenase-2 inhibitors and potassium channel activators

Info

Publication number
AU2298301A
AU2298301A AU22983/01A AU2298301A AU2298301A AU 2298301 A AU2298301 A AU 2298301A AU 22983/01 A AU22983/01 A AU 22983/01A AU 2298301 A AU2298301 A AU 2298301A AU 2298301 A AU2298301 A AU 2298301A
Authority
AU
Australia
Prior art keywords
inhibitors
flavones
cyclooxygenase
nitric oxide
potassium channel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU22983/01A
Inventor
Yang Ling Ling Chen
Tony Jer-Fu Lee
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Southern Illinois University System
Original Assignee
Southern Illinois University Edwardsville
Southern Illinois University Carbondale
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Southern Illinois University Edwardsville, Southern Illinois University Carbondale filed Critical Southern Illinois University Edwardsville
Publication of AU2298301A publication Critical patent/AU2298301A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7024—Esters of saccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU22983/01A 1999-10-20 2000-10-20 Flavones as inducible nitric oxide synthase inhibitors, cyclooxygenase-2 inhibitors and potassium channel activators Abandoned AU2298301A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US16061299P 1999-10-20 1999-10-20
US60160612 1999-10-20
PCT/US2000/041396 WO2001030342A1 (en) 1999-10-20 2000-10-20 Flavones as inducible nitric oxide synthase inhibitors, cyclooxygenase-2 inhibitors and potassium channel activators

Publications (1)

Publication Number Publication Date
AU2298301A true AU2298301A (en) 2001-05-08

Family

ID=22577612

Family Applications (1)

Application Number Title Priority Date Filing Date
AU22983/01A Abandoned AU2298301A (en) 1999-10-20 2000-10-20 Flavones as inducible nitric oxide synthase inhibitors, cyclooxygenase-2 inhibitors and potassium channel activators

Country Status (2)

Country Link
AU (1) AU2298301A (en)
WO (1) WO2001030342A1 (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA80682C2 (en) * 2001-08-06 2007-10-25 Pharmacia Corp Orally deliverable stabilized oral suspension formulation and process for the incresaing physical stability of thixotropic pharmaceutical composition
DE10139793A1 (en) * 2001-08-14 2003-02-27 Beiersdorf Ag Use of wogonin for the production of cosmetic or dermatological preparations for the prophylaxis and treatment of inflammatory skin conditions and / or for skin protection in the case of sensitive, dry skin
DE10139791A1 (en) * 2001-08-14 2003-02-27 Beiersdorf Ag Use of Oroxylin A for the production of cosmetic or dermatological preparations for the prophylaxis and treatment of inflammatory skin conditions and / or for skin protection in the case of sensitive, dry skin
EP1808172A3 (en) * 2002-03-06 2010-05-26 Activephyto Technologies Limited Botanical extract compositions and methods of use
DE60313754T2 (en) * 2002-03-06 2008-01-24 The Medical Research and Education Trust, San Diego BOTANICAL EXTRACT WITH ANTICIPATIVE ACTIVITY INCLUDING ISOLIQUIRITIGENIN
US6884783B2 (en) 2002-05-03 2005-04-26 Unigen Pharmaceuticals, Inc. 7-Hydroxy chromones as potent antioxidants
US6740677B2 (en) * 2002-08-19 2004-05-25 Hong Xue Methods of treating benzodiazepine site (BZD-S) associated syndromes using 2′ hydroxyflavonoids
WO2004016265A1 (en) * 2002-08-19 2004-02-26 Phamacogenetics Limited Methods of predicting gabaa receptor efficacies for flavonoid compounds and uses therefor
CA2502975A1 (en) * 2002-10-22 2004-05-06 Jenken Biosciences, Inc. Chromones and chromone derivatives and uses thereof
KR100609007B1 (en) * 2003-12-09 2006-08-09 한국화학연구원 Chrysine derivatives selectively inhibit CO2 enzyme
TWI454261B (en) 2007-01-09 2014-10-01 Unigen Inc Color ketones as therapeutic agents
CN105078957B (en) * 2014-05-04 2017-11-21 中国医学科学院基础医学研究所 Trihydroxyflavone is preparing the purposes in being used to treat or prevent the medicine of abdominal aneurvsm
CN107556278A (en) * 2017-09-08 2018-01-09 湖北中医药大学 A kind of the flavanone alcohols compound and its preparation method and purposes of fluorine substitution
CN113750085B (en) * 2020-06-02 2023-08-29 中国科学院上海药物研究所 Use of natural compounds and derivatives thereof for the treatment of arterial lesions

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU8588398A (en) * 1997-07-25 1999-02-16 Duke University Composition for protection from damage by ischemia

Also Published As

Publication number Publication date
WO2001030342A1 (en) 2001-05-03
WO2001030342A9 (en) 2001-10-18

Similar Documents

Publication Publication Date Title
ZA98179B (en) Nitric oxide synthase inhibitors.
MXPA03000772A (en) Hexahydro-7-1h-azepin-2-yl-haxanoic acid derivatives as inhibitors of inducible nitric oxide synthase.
AU2001245704A1 (en) High performance carburizing stainless steel for high temperature use
AU2003278039A1 (en) Nitric oxide releasing selective cyclooxygenase-2 inhibitors
AU2298301A (en) Flavones as inducible nitric oxide synthase inhibitors, cyclooxygenase-2 inhibitors and potassium channel activators
MXPA03002207A (en) 2-amino-2-alkyl-5 heptenoic and heptynoic acid derivatives useful as nitric oxide synthase inhibitors.
AP2000001998A0 (en) Nitric oxide synthase inhibitors
GB0031179D0 (en) Nitric oxide synthase inhibitors
AU2001265154A1 (en) Method and composition for targeting an adenoviral vector
AU2003211120A1 (en) Removable labels, coupons and the like
MXPA02012890A (en) Methods for increasing nitric oxide synthase activity.
AU2002234076A1 (en) Construction composition, structure, and method
MXPA02010068A (en) Halogentated 2 amino 5,6 heptenoic acid derivatives useful as nitric oxide synthase inhibitors.
AU2001215798A1 (en) Click-to-add, jot-it-down, and add banner
AU4411399A (en) Potassium channel inhibitors
AU2002226266A1 (en) Amine derivative with potassium channel regulatory function, its preparation and use
AU2001282746A1 (en) Novel phenylheteroazetidines, useful as nitric oxide synthase inhibitors
AU2003295782A1 (en) Pyridinyl, pyrimidinyl and pyrazinyl amides as potassium channel openers
AU2001265096A1 (en) Short-root gene, promoter, and uses thereof
AU2001280591A1 (en) Modulation of nitric oxide synthase by pkc
MXPA03002271A (en) 2-amino-2-alkyl-3 hexenoic and hexynoic acid derivatives useful as nitric oxide synthase inhibitors.
AU2002350575A1 (en) Selective neuronal nitric oxide synthase inhibitors
AU4945300A (en) Amplifier with improved, high precision, high speed and low power consumption architecture
AU2001232075A1 (en) Compound, composition and use
AU2002245127A1 (en) Oxazolidinone photoaffinity probes, uses and compounds

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase